Evaluation of the Disease Burden of Sporadic Creutzfeldt-Jacob Disease with the Surveillance Data from 2013 to 2017 in China

Chen Gao,Lina Zhang,Kang Xiao,Wei Zhou,Yuan Wang,Cao Chen,Qi Shi,Xiao-Ping Dong

DOI: https://doi.org/10.21203/rs.3.rs-44947/v2

2020-01-01

Abstract:Background Sporadic Creutzfeldt-Jacob disease (sCJD) is the commonest type of human prion disease and cause 100% fatality. The morbidity of sCJD is about 1 to 2 cases/million/year worldwide.Methods In this study, the disease burden of sCJD in China was evaluated based on the data of Chinese National CJD Surveillance from 2013 to 2017.Results The Disability-Adjusted Life Year (DALY) of sCJD was measured with 753 probable sCJD patients. The total DALY of 753 sCJD cases in the past five surveillance years was 16202.62 person-years. The Years of Life Lost (YLL) was the predominant component for DALY reaching to more than 95%, while the Years Lost due to Disability (YLD) accounted for less than 5% only. The highest DALY was noticed in the group of 45-50 year-old (6541.49), followed by the groups of 60-69 year-old (6311.25). Furthermore, the indirect economic burdens of 753 sCJD patients were estimated with the official capital data. Total indirect economic burden for five years was 372.08 million RMB (1US $=6.9 RMB), with the average of 494,133 RMB per case. The patients aged 45-59 years old were the predominant population that accounted for approximate 73% of total indirect economic burden. Although still lacking the exact annual incidence of sCJD in China, the DALY intensity of sCJD in China could be estimated and predicted as 2.2 to 4.4 person-years /100,000 with the global morbidity of sCJD.Conclusion This is the first disease burden assay for sCJD in China, which will supply fundamental evidence for further development of medical strategy.